Mumbai (Maharashtra) [India], June 26 (ANI): Fast-moving consumer goods major Hindustan Unilever Ltd (HUL) said on Friday it has completed the acquisition of intimate hygiene brand VWash from Glenmark Pharmaceuticals.
Mumbai (Maharashtra) [India], June 22 (ANI): Equity benchmark indices wiped out early gains but closed over half a per cent higher on Monday led by gains in banking, pharma and metal stocks.
Mumbai (Maharashtra) [India], June 22 (ANI): Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to Rs 531.80 per unit after it became the first pharmaceutical company in India to receive regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to
Mumbai (Maharashtra) [India], May 26 (ANI): Glenmark Pharmaceuticals on Tuesday announced a new randomised, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential Covid-19 treatment strategy.
Mumbai (Maharashtra) [India], May 12 (ANI): Glenmark Pharmaceuticals has initiated phase three of clinical trials in India on antiviral tablet Favipiravir, becoming the first company in the country to do so.
Mumbai (Maharashtra) [India], April 30 (ANI): Glenmark Pharmaceuticals said on Thursday it has received approval from the Drug Controller General of India (DCGI) to conduct clinical trials on Favipiravir anti-viral tablets on COVID-19 patients.
Mumbai (Maharashtra) [India], Mar 24 (ANI): The share price of FMCG major Hindustan Unilever Ltd (HUL) jumped by over 8 per cent on Tuesday afternoon after the company signed an agreement with Glenmark Pharmaceuticals to acquire its intimate hygiene brand VWash.
Mumbai (Maharashtra) [India], Oct 7 (ANI): The US Food and Drug Administration (US FDA) has issued a warning letter to Glenmark Pharmaceuticals for breach of norms at its facility at Baddi in Himachal Pradesh.
Mumbai (Maharashtra) [India], Aug 14 : Glenmark Pharmaceuticals has reported a consolidated net profit of Rs 109 crore for the quarter ended June 30 as compared to Rs 232 crore in the previous corresponding quarter, registering a decrease of 53 per cent
Mumbai (Maharashtra) [India], July 11 (ANI): Fitch Ratings on Thursday affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at 'BB' with a stable outlook.